Found "AI": 1,093 results
Distributing ‘Smart Watch’ alone cannot reduce Sedentary Behavior. An Active Lifestyle can be encouraged by harmonizing Individual, Social, Organizational, and Environmental levels.
Sedentary behavior and physical inactivity increase the risks of non-communicable diseases such as hypertension, diabetes, and cardiovascular diseases, which contribute to approximately 70% of all-cause mortality among Thais.
There is a misunderstanding that exercise in leisure time can n
High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic in Thailand
Over the past 5 years, HCUs (i.e., top 5% of the population) utilized ~50% of the annual health expenditure, confirming that even during the pandemic year of 2020, the HCU phenomenon still existed.
The characteristics of HCU patients remained relatively the same from 2016 to 2020, in terms of pro
Unpacking Digital Health: A breakdown of concepts and definitions
Digital health is an umbrella term that includes all healthcare services that are provided by ICT. From one’s personal wearable devices to the use of big data and AI in healthcare come under digital health’
Under the umbrella of digital health technology, various sub-groups such as electronic
Value Distribution in New Branded Medicines: How Much Benefits Patients Versus Manufacturers?
Thailand has successfully implemented economic evaluation to inform the inclusion of new, branded medicines within its National List of Essential Medicines (NLEM). This method can be used to assess the health value that new medicines will generate for patients after accounting for the health los
Towards A Sustainable Kidney Replacement Therapy Program: Recommendations For Thailand’s 2022 Dialysis Reform
The National Health Security Office Working Group (NHSO WG) conducted structured, evidence-based deliberations to generate recommendations for the National Health Security Board on the kidney replacement therapy (KRT) policy.
These are the proposed recommendations:
To consider defining KRT p
Research for development of an optimal policy strategy for prevention and control of cervical cancer in Thailand
Cervical cancer is a global public health problem, with approximately 500,000 new cases are identified each year globally. The disease is the most common cancer in women in the developing world and its mortality is very high–nearly 300,000 per year, 80% of which are in resource-poor settings. Human papillomavirus (HPV) has been proven as a major
Economic evaluation of seasonal influenza vaccine among pregnant women in Thailand
10-383-2556pregnant women,seasonal influenza vaccine,vaccine
Advanced health biotechnologies in Thailand: State of the art, future trends and strategic preparation
Aiming at appropriate preparation for the future development of individualized and regenerative medicine (in particular, gene, stem cell and tissue engineering therapies), the Health Intervention and Technology Assessment (HITAP) program has agreed to conduct a study to provide an insight on elements necessary for national policymaking in Thailand.
Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs
The Cancer Drug Fund (CDF) is a dedicated source of funding in England for increasing patient access to high-cost cancer drugs, with a fixed budget of £340 million per year, operating since 2016.
The CDF follows the appraisal by the National Institute of Health and Care Excellence (NICE) whic
Health Financing during COVID-19 responses in Thailand
Thailand spent 440,023 million baht on healthcare in response to the COVID-19 pandemic in 2020–2022, of which 257,892 million baht went toward COVID-19 tests, treatments, and vaccination services.
In addition to having higher hospital reserves than in the pre-pandemic period, private hospital
10 / Page